Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer.

× No keyword cloud information.

63 in total

1. Next-generation sequencing for cancer diagnostics: a practical perspective.

Authors: Cliff Meldrum; Maria A Doyle; Richard W Tothill
Journal: Clin Biochem Rev Date: 2011-11

Review 2. Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors: Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal: Nat Rev Clin Oncol Date: 2010-06-15 Impact factor: 66.675

Review 3. Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Authors: Jente van Staalduinen; David Baker; Peter Ten Dijke; Hans van Dam
Journal: Oncogene Date: 2018-07-12 Impact factor: 9.867

4. Clinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation.

Authors: Hui Ning; Ming Liu; Lina Wang; Yang Yang; Nan Song; Xiaoxiong Xu; Jin Ju; Gening Jiang
Journal: J Thorac Dis Date: 2017-03 Impact factor: 2.895

5. Posttranslational modifications of FOXO1 regulate epidermal growth factor receptor tyrosine kinase inhibitor resistance for non-small cell lung cancer cells.

Authors: Zhi-hong Xu; Wen-wen Shun; Jun-biao Hang; Bei-li Gao; Jia-an Hu
Journal: Tumour Biol Date: 2015-06-03

Review 6. Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Authors: Salvatore Corallo; Ettore D'Argento; Antonia Strippoli; Michele Basso; Santa Monterisi; Sabrina Rossi; Alessandra Cassano; Carlo M Barone
Journal: Target Oncol Date: 2017-04 Impact factor: 4.493

7. MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway.

Authors: Juan Du; LiNa Wang; ChenXi Li; HuiLun Yang; YuanBo Li; Haiyang Hu; Hui Li; ZongFeng Zhang
Journal: Tumour Biol Date: 2015-10-19

8. The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma.

Authors: Fang Wu; Junhe Li; Changchen Jang; Janfeng Wang; Jianping Xiong
Journal: Int J Clin Exp Pathol Date: 2014-09-15

Review 9. Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.

Authors: Nikhil G Thaker; Ian F Pollack
Journal: Expert Rev Neurother Date: 2009-12 Impact factor: 4.618

10. Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancer.

Authors: Hua-Jun Chen; Tony S Mok; Zhi-Hong Chen; Ai-Lin Guo; Xu-Chao Zhang; Jian Su; Yi-Long Wu
Journal: Pathol Oncol Res Date: 2009-04-21 Impact factor: 3.201